Metraipolis › archive › dc_7083079e98dd
First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From ALK-Rearranged NSCLC: Case Report — Europe PMC PMID:41584719
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41584719
- DOI
- 10.1016/j.jtocrr.2025.100941
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T16:46:10.751Z
- SHA-256 of the archived text
67a5478665b5b5b761ef2312defdbad0a6220551864480cb56e2abcc8ab54ca1- Stable URL of this page
https://metraipolis.com/documento/dc_7083079e98dd
How to cite
First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From ALK-Rearranged NSCLC: Case Report — Europe PMC PMID:41584719 — Europe PMC (en), https://europepmc.org/article/MED/41584719 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7083079e98dd (Metraipolis archive dc_7083079e98dd, sha256 67a5478665b5b5b761ef2312defdbad0a6220551864480cb56e2abcc8ab54ca1)
BibTeX
@misc{dc7083079e98dd,
title = {First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From ALK-Rearranged NSCLC: Case Report — Europe PMC PMID:41584719},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41584719},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7083079e98dd; sha256 67a5478665b5b5b761ef2312defdbad0a6220551864480cb56e2abcc8ab54ca1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41584719. Agents can read the archived copy with the MCP tool read_document.